Trivitron Healthcare, NeoGen Labs, Danone India and Rainbow Children’s Hospitals Hosts the 2017

Bangalore, October 30, 2017 – Trivitron Healthcare in association with NeoGen Labs hosted the 2017 Newborn Screening Symposium on October 30, 2017 in Bangalore. Newborn Screening (NBS) is a test performed on babies, normally 24 to 72 hours after birth, to identify “Inborn Errors of Metabolism”, or IEMs, and to treat them if they are identified for before they are adversely impacted. Trivitron has introduced state of the art technology in India to support NBS to improve neonatal care and ensure babies start their life healthy.

The symposium was organized by National Neonatology Forum(NNF), Karnataka Chapter, and was supported by Trivitron Healthcare, NeoGenLabs, Danone India and Rainbow Children’s Hospital, in a collective effort, toincrease awareness of the benefits of NBS in the medical community to improvethe lives of babies born in India.

IEMs if detected early, and treated immediately, can lead tonormal healthy babies who grow into productive adults contributing to society.These disorders move fast and if left untreated, they can result in developmentdelays, mental retardation, physical handicaps and even death. Technologyavailable from Trivitron Healthcare, today, can detect these disorders in ababy as soon as the second day of life and presents a window of opportunity toaddress them before any harm can be done.

NBS is a public health program in many countries and is asimportant as routine vaccinations. It should be done routinely on every babythat is born in India. It helps in reducing the Infant Mortality Rates (IMR).Nearly 100 medical professionals took part in the symposium held at GrandMagrath Hotel, Bangalore.

Dr. G S K Velu, Chairman & Managing Director,Trivitron Healthcare, stated “It is very important to make NewbornScreening mandatory in India. While this is an essential neonatal service thatis mandated in the developed world, India lags far behind in it, resulting inserious health disorders affecting our society and economy.”

Mr. Thomas Mookken, Founder & CEO, NeoGen Labs said“NeoGen believes that NBS saves lives. It is also very critical for a lab to doa screening test right since a baby’s life depends on it. At 

NeoGen Labs, we continuously invest in people, process andtechnology to create a screening test result we can stand behind and aphysician can trust. After all, every baby is precious!”

Dr. Madhavi Marathe, Senior Manager (Nutrition andR&D), Danone India emphasised that “Children with IEMs requirespecial diets without which the prognosis of the disease is very poor and thesechildren often die. These specialised diets are now available in India for 15IEM conditions through a special initiative ‘Diet4life’ launched by Food Safetyand Standards Authority of India (FSSAI). Danone India is one of the partnersin this initiative and has already made these diets available in India”

Dr. Rajath Athreya, Lead Consultant Neonatologist,Rainbow Children's Hospital, Marathalli, said “Healthcare has thedilemma of matching resources to public health initiatives. Althoughindividually rare, as a group the disorders that can be screened for in anapparently healthy newborn aren't that uncommon. Newborn Screening will becomean important tool to ensure lifelong health of coming generations. Screeningand then, diligently, managing cases has to go hand in hand. Today's symposiumaddressed challenges in setting up screening programs and managing thesemedical conditions. Medical experts and families with children with IEM sharedtheir expertise and experiences.” 

About Trivitron Healthcare:

The genesis of Trivitron Healthcare Private Limited, datesback to 1997, when Dr. Velu, a first generation entrepreneur decided to build acompany on the premise of delivering cost effective medical technologysolutions and services to the underserved. Today, Trivitron Healthcare, throughsuccessful inorganic synergies with local and global firms and is the largestmedical technology company, with products exported to over 165 countries. 

About NeoGen Labs:

NeoGen Labs was founded in 2006 and is a leading provider ofNewborn Screening services in India. NeoGen Labs has a singular focus onNewborn Screening and does not do any other tests. Premier hospitals in Indiaand abroad contract with NeoGen for the First Step Newborn Screening 

Test to ensure that infants have a healthy start at thebeginning of life. More information on NeoGen Labs can be found at www.neogenlabs.com.


  (0)   Comment